Add to ORKGHigh plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherap
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death. The American Societ...
Hyponatremia affects nearly one in five of all hospitalized patients. Severe hyponatremia is associa...
© Balachandran et al.Background: Hyponatraemia is a common finding in patients with cancer, and has ...
Vikram Gota,1 Krunal Kavathiya,1 Kartik Doshi,1 Murari Gurjar,1 Solai E Damodaran,1 Vanita Noronha,2...
Background and Objectives: Hyponatremia is among the most prevalent electrolyte abnormalities observ...
International audienceINTRODUCTION:The small cell lung cancer (SCLC) is a rapidly progressive malign...
Hyponatremia (serum Na levels of <135 mEq/L) is the most common electrolyte imbalance encountered in...
Hyponatraemia has been reported with targeted therapies in cancer patients. Aim of the study was to ...
Hyponatraemia has been reported with targeted therapies in cancer patients. Aim of the study was to ...
Hyponatremia is the most common electrolyte disorder encountered in hospitalized patients. This appl...
Pemetrexed is a cytotoxic drug for first-line treatment of lung cancer. It is often combined with ot...
Hyponatremia is the most common electrolyte disorder in lung cancer patients. This condition may be ...
Hyponatremia is the most frequently observed electrolyte abnormality in clinical practice, and its f...
Background: Hyponatremia in cancer patients is often caused by the syndrome of inappropriate antidiu...
Item does not contain fulltextPemetrexed is a cytostatic antifolate drug and a cornerstone in the tr...
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death. The American Societ...
Hyponatremia affects nearly one in five of all hospitalized patients. Severe hyponatremia is associa...
© Balachandran et al.Background: Hyponatraemia is a common finding in patients with cancer, and has ...
Vikram Gota,1 Krunal Kavathiya,1 Kartik Doshi,1 Murari Gurjar,1 Solai E Damodaran,1 Vanita Noronha,2...
Background and Objectives: Hyponatremia is among the most prevalent electrolyte abnormalities observ...
International audienceINTRODUCTION:The small cell lung cancer (SCLC) is a rapidly progressive malign...
Hyponatremia (serum Na levels of <135 mEq/L) is the most common electrolyte imbalance encountered in...
Hyponatraemia has been reported with targeted therapies in cancer patients. Aim of the study was to ...
Hyponatraemia has been reported with targeted therapies in cancer patients. Aim of the study was to ...
Hyponatremia is the most common electrolyte disorder encountered in hospitalized patients. This appl...
Pemetrexed is a cytotoxic drug for first-line treatment of lung cancer. It is often combined with ot...
Hyponatremia is the most common electrolyte disorder in lung cancer patients. This condition may be ...
Hyponatremia is the most frequently observed electrolyte abnormality in clinical practice, and its f...
Background: Hyponatremia in cancer patients is often caused by the syndrome of inappropriate antidiu...
Item does not contain fulltextPemetrexed is a cytostatic antifolate drug and a cornerstone in the tr...
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death. The American Societ...
Hyponatremia affects nearly one in five of all hospitalized patients. Severe hyponatremia is associa...
© Balachandran et al.Background: Hyponatraemia is a common finding in patients with cancer, and has ...